D. M. Bamberger. “Outcome of Medical Treatment of Bacterial Abscesses without Therapeutic Drainage: Review of Cases Reported in the Literature,” Clinical Infectious Disease, Vol. 23, No. 3, 1996, pp. 592-603. doi:10.1093/clind/23.1.592
 D. M. Bamberger, B. L. Herndon, M. Dew, R. P. Chern, H. Mitchell, L. E. Summers, R. F. Marcus, S. C. Kim and P. R. Suvarna, “Efficacies of Ofloxacin, Rifampin, and Clindamycin in Treatment of S. aureus Abdominal Abscesses and Correlation with Results of an in Vitro Assay of Intracellular Bacterial Killing,” Antimicrobial Agents & Chemotherapy, Vol. 41, No. 5, 1997, pp. 1178-1181.
 D. M. Bamberger and B. L. Herndon, “Bactericidal Capacity of Neutrophils in Rabbits with Experimental Acute and Chronic Abscesses,” Journal of Infectious Disease, Vol. 162, No. 1, 1990, pp. 186-192. doi:10.1093/infdis/162.1.186
 D. M. Bamberger, B. L. Herndon, J. Fitch, A. Florkowski and V. Parkhurst, “The Effect of Neutrophils on Cefazolin Activity and Penicillin Binding Proteins in Staphylococcus aureus Abscesses,” Antimicrobial Agents & Chemotherapy, Vol. 46, No. 9, 2002, pp. 2878-2884. doi:10.1128/AAC.46.9.2878-2884.2002
 H. D. Gresham, J. H. Lowrance, T. E. Caver, B. S. Wilson, A. L. Cheung and F. P. Lindberg, “Survival of Staphylococcus aureus inside Neutrophils Contributes to Infection,” Journal of Immunology, Vol. 164, No. 7, 2000, pp. 3713-3722.
 J. M. Voyich, K. R. Braughton, D. E. Studevant, A. R. Whiney, B. Said-Salim, S. F. Porcella, et al., “Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils,” Journal of Immunology, Vol. 175, No. 6, 2005, pp. 3907-3919.
 S. Turk, O. Verlaine, T. Gerards, M. Zivec, J. Humljan, I. Sosic, A. Amoroso, A. Zervosen, A. Luxen, B. Joris and S. Gobec, “New Noncovalent Inhibitors of Penicilin-Binding Proteins from Penicillin-Resistant Bacteria,” PLoS ONE, Vol. 6, No. 5, 2011, Article ID: e19418. doi:10.1371/journal.pone.0019418
 S. Bobba and W. G. Gutheil, “Multivariate Geometrical Analysis of Ctralytic Residues in the Penicillin-Binding Proteins,” The International Journal of Biochemistry & Cell Biology, Vol. 43, No. 10, 2011, pp. 1490-1499. doi:10.1016/j.biocel.2011.06.012
 N. H. Georgopapadakou, S. A. Smith, and D. P. Bonner, “Penicillin-Binding Proteins in a Staphylococcus aureus Strain Resistant to Specific β-Lactam Antibiotics,” Antimicrobial Agents & Chemotherapy, Vol. 22, No. 1, 1982, pp. 172-175.
 P. C. Taylor, F. D. Schoenknecht, J. C. Sherris and E. C. Linner, “Determination of Minimum Bactericidal Concentrations of Oxacillin for Staphylococcus aureus: Influence and Significance of Technical Factors,” Antimicrobial Agents & Chemotherapy, Vol. 23, No. 1, 1983, pp. 142-150.
 National Committee for Clinical Laboratory Standards, “Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard—11th Edition,” Vol. 32, No. 1, Clinical and Laboratory Standards Institute, Wayne, USA, 2012.
 A. Koomer, T. Quinn, D. Bamberger and B. L. Herndon, “Neutrophil-Antimicrobial Interaction in the Established Infection: Effect on Staphylococcus aureus,” Journal of Infection, Vol. 52, No. 5, 2006, pp. 288-320. doi:10.1016/j.jinf.2005.07.017
 A. Tomasz, H. B. Drugeon, H. M. de Lencastre, D. Jabes, L. McDougall and J. Bille, “New Mechanism for Methicillin Resistance in Staphylococcus aureus: Clinical Isolates That Lack the PBP 2a Gene and Contain Normal Penicillin-Binding Proteins with Modified PenicillinBinding Capacity,” Antimicrobial Agents & Chemotherapy, Vol. 33, No. 11, 1989, pp. 1869-1874.
 D. L. Stevens, S. Yan and A. E. Bryant, “PenicillinBinding Protein Expression at Different Growth Stages Determines Penicillin Efficacy in Vitro and in Vivo: An Explanation for the Inoculum Effect,” Journal of Infectious Diseases, Vol. 167, No. 6, 1993, pp. 1401-1405. doi:10.1093/infdis/167.6.1401